Eli Lilly to Build $6.5 Billion Texas Facility to Boost U.S. Ingredient Manufacturing

Pfizer's recent agreement to acquire Metsera for up to $7.3 billion marks a significant return to the obesity drug market, especially after the company previously abandoned an experimental weight-loss pill. This move is crucial as it highlights Pfizer's commitment to addressing the growing obesity epidemic and capitalizing on the increasing demand for effective weight-loss solutions.

The FDA's recent approval of a new drug for autism has sparked significant discussion about the review process for medications targeting this condition. This approval is noteworthy as it may change how future treatments are evaluated, potentially leading to quicker access for patients. The implications of this decision could reshape the landscape of autism treatment and influence how similar drugs are assessed in the future.

Sea moss has gained popularity among wellness influencers who tout its benefits for gut health, anxiety reduction, and skin improvement. However, the scientific evidence supporting these claims remains unclear. As more people turn to natural remedies for health and beauty, understanding the effectiveness of sea moss is crucial for consumers looking to make informed choices.

A judge has ordered the National Institutes of Health (NIH) to reinstate suspended research grants at the University of California, Los Angeles (UCLA). This decision is significant as it allows vital research projects to continue, which could lead to important medical advancements. The ruling highlights the importance of funding in scientific research and the role of institutions like the NIH in supporting innovation.

The debate surrounding Tylenol and its potential link to autism continues, with President Trump's assertions adding to the confusion. Parents are left navigating this complex issue, as the scientific evidence remains inconclusive. It's crucial for families to stay informed and make decisions based on the best available information regarding acetaminophen use.

Public health expert Lawrence Gostin has criticized President Donald Trump's recent comments suggesting a link between paracetamol and autism, stating that such claims are 'utterly reckless.' The World Health Organization has confirmed that neither Tylenol nor vaccines have been shown to cause autism, emphasizing the importance of relying on scientific evidence. This matter is crucial as misinformation can lead to public health risks and undermine trust in vaccines, which are vital for preventing disease.

World health officials have firmly rejected President Trump's claims that Tylenol could be linked to autism, particularly for pregnant women. This is significant because it highlights the importance of relying on scientific evidence over unverified assertions, especially when it comes to the health of expectant mothers and their babies. The World Health Organization reassures that Tylenol is safe to use during pregnancy, emphasizing the need for accurate information in public health discussions.